Your browser doesn't support javascript.
loading
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Koshiro, Nishimoto; Nakajima, Kenichi; Oyama, Masafumi; Kaneko, Go; Takahashi, Satoru; Matsuyama, Hideyasu; Shiina, Hiroaki; Ichikawa, Tomohiko; Horikoshi, Hiroyuki; Hashine, Katsuyoshi; Sugiyama, Yutaka; Miyao, Takeshi; Kamiyama, Manabu; Harada, Kenichi; Ito, Akito; Mizokami, Atsushi.
Afiliação
  • Koshiro N; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Nakajima K; Department of Functional Imaging and Artificial Intelligence, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Oyama M; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Kaneko G; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Takahashi S; Department of Urology, Nihon University School of Medicine, Tokyo, Japan.
  • Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
  • Shiina H; Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan.
  • Ichikawa T; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Horikoshi H; Department of Diagnostic Radiology, Gunma Prefectural Cancer Center, Ota, Japan.
  • Hashine K; Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Sugiyama Y; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Miyao T; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Kamiyama M; Department of Urology, University of Yamanashi, Yamanashi, Japan.
  • Harada K; Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Ito A; Department of Urology, Iwate Medical University, Iwate, Japan.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Int J Urol ; 29(12): 1477-1487, 2022 12.
Article em En | MEDLINE | ID: mdl-36070138
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Int J Urol Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Int J Urol Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão